The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Successful intercourse was improved by 30% and 37% in the tadalafil 10 mg and 20 mg groups, respectively, compared with 4% in the placebo group (p < 0.001).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Fonseca et al 2004
In the citing paper
“Comorbid conditions more common in the patients with diabetes included hypertension, hyperlipidemia, and coronary artery disease (Fonseca et al 2004).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Fonseca et al 2004
In the citing paper
“The average age was 57, and diabetic men had more severe ED than patients without diabetes at baseline with a mean IIEF-EF of 12.6 compared to 15 in patients without diabetes (p < 0.001).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Fonseca et al 2004
In the citing paper
“Diabetic men in the tadalafil 10 mg and 20 mg groups had improvements of 6.2 and 7.4 in their IIEF-EF, respectively, versus 0.9 for placebo (p < 0.001) (Fonseca et al 2004).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Fonseca et al 2004
In the citing paper
“Overall, erections were reported as improved in 75% for the 20 mg group, 61% for the 10 mg group, and 30% for the placebo group (Fonseca et al 2004).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Fonseca et al 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
(1999) · doi:10.1016/s0090-4295(99)00099-0 · Cited by 1,051
Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201093260203 · Cited by 1,006
Research works printed but not linked: 28
- Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R (2001) Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 166:569?574 · DOI · Paper page
- Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U (2000) Epidemiology of erectile dysfunction: results of the ?Cologne Male Survey?. Int J Impot Res 12:305?311 · DOI
- Penson D, Latini D, Lubeck D, Wallace K, Henning J, Lue T (2003) Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 26:1093?1099 · DOI · Paper page
- Knispel HH, Goessl C, Beckmann R (1992) Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urol Res 20:253?257 · DOI
- Davidoff MS, Middendorff R, Mayer B, deVente J, Koesling D, Holstein AF (1997) Nitric oxide/cGMP pathway components in the Leydig cells of the human testis. Cell Tissue Res 287:161?170 · DOI
- Boolell M, Allen MJ, Ballard SA et al. (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8:47?52
- Brock GB, McMahon CG, Chen KK et al. (2002) Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332?1336 · DOI · Paper page
- Hellstrom WJ, Gittelman M, Karlin G et al. (2002) Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 23:763?771 · DOI · Paper page
- Noyman I, Marikovsky M, Sasson S et al. (2002) Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells. Nitric Oxide 7:187?193 · DOI
- Booth G, Stalker T, Lefer A, Scalia R (2001) Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 280:E848?E856 · DOI
- Graier WF, Posch K, Fleischhacker E, Wascher TC, Kostner GM (1999) Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract 45:153?160 · DOI
- Fonseca V, Desouza C, Asnani S, Jialal I (2004) Nontraditional risk factors for cardiovascular disease in diabetes. Endocrine Reviews 25:153?175 · DOI
- Desouza C, Akers D, Parulkar A, Fonseca VA, Lumpkin D (2002) Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 25:1336?1339 · DOI
- Calles-Escandon J, Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36?52 · DOI · Paper page
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49:822?830 · DOI · Paper page
- Vinik A, Richardson D (1998) Erectile dysfunction in diabetes. Diabetes Rev 6:16?33
- Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ (2004) Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43:179?184 · DOI
- Williams SB, Goldfine AB, Timimi FK et al. (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695?1701 · DOI · Paper page
- Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27:567?574 · DOI · Paper page
- Cellek S, Foxwell NA, Moncada S (2003) Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52:2353?2362 · DOI
- Cellek S, Qu W, Schmidt AM, Moncada S (2003) Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 47:331?339 · DOI
- Saenz De Tejada I, Anglin G, Knight JR, Emmick JT (2002) Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 25:2159?2164 · DOI · Paper page
- Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T (2003) Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 26:777?783 · DOI
- Price DE, Gingell JC, Gepi-Attee S, Wareham K, Yates P, Boolell M (1998) Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet Med 15:821?825 · DOI
- Rendell MS, Rajfer J, Wicker PA, Smith MD (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 281:421?426 · DOI
- Stuckey BG, Jadzinsky MN, Murphy LJ et al. (2003) Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 26:279?284 · DOI
- Romeo JH, Seftel AD, Madhun ZT, Aron DC (2000) Sexual function in men with diabetes type 2: association with glycemic control. J Urol 163:788?791 · DOI · Paper page
- Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R (2003) Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 62:121?125 · DOI · Paper page
Cited by
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish, A. M., Saad, F., & Guay, A. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005751 · Cited by 266
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment
Hatzimouratidis, K., & Hatzichristou, D. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0545-6 · Cited by 68
Bajaj, H. S., Gerstein, H. C., Rao-Melacini, P., Basile, J., Colhoun, H., Conget, I., Cushman, W. C., Dagenais, G. R., Franek, E., Hanefeld, M., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00115-7 · Cited by 56
Evaluation and Management of Erectile Dysfunction
Burnett, A. L. (2012) · Campbell-Walsh Urology · doi:10.1016/b978-1-4160-6911-9.00024-4 · Cited by 28
Metadata
- Authors
- Fonseca, V., Seftel, A., Denne, J., & Fredlund, P.
- Venue
- Diabetologia
- Published
- 2004-11
- Volume
- 47
- Issue
- 11
- Pages
- 1914-1923
- ISSN
- 0012-186X
- 1432-0428
- Cited by
- 136
- References
- 4
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
